These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 27625151)

  • 1. Synthesis and mechanisms of action of novel harmine derivatives as potential antitumor agents.
    Zhang XF; Sun RQ; Jia YF; Chen Q; Tu RF; Li KK; Zhang XD; Du RL; Cao RH
    Sci Rep; 2016 Sep; 6():33204. PubMed ID: 27625151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diallyl trisulfide induces osteosarcoma cell apoptosis through reactive oxygen species-mediated downregulation of the PI3K/Akt pathway.
    Wang H; Sun N; Li X; Li K; Tian J; Li J
    Oncol Rep; 2016 Jun; 35(6):3648-58. PubMed ID: 27035545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumor and neurotoxic effects of novel harmine derivatives and structure-activity relationship analysis.
    Chen Q; Chao R; Chen H; Hou X; Yan H; Zhou S; Peng W; Xu A
    Int J Cancer; 2005 May; 114(5):675-82. PubMed ID: 15609303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual inhibition of PI3K and mTOR mitigates compensatory AKT activation and improves tamoxifen response in breast cancer.
    Chen X; Zhao M; Hao M; Sun X; Wang J; Mao Y; Zu L; Liu J; Shen Y; Wang J; Shen K
    Mol Cancer Res; 2013 Oct; 11(10):1269-78. PubMed ID: 23814023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pro-apoptotic and pro-autophagic effects of the Aurora kinase A inhibitor alisertib (MLN8237) on human osteosarcoma U-2 OS and MG-63 cells through the activation of mitochondria-mediated pathway and inhibition of p38 MAPK/PI3K/Akt/mTOR signaling pathway.
    Niu NK; Wang ZL; Pan ST; Ding HQ; Au GH; He ZX; Zhou ZW; Xiao G; Yang YX; Zhang X; Yang T; Chen XW; Qiu JX; Zhou SF
    Drug Des Devel Ther; 2015; 9():1555-84. PubMed ID: 25792811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological evaluation of N(9)-substituted harmine derivatives as potential anticancer agents.
    Du H; Tian S; Chen J; Gu H; Li N; Wang J
    Bioorg Med Chem Lett; 2016 Aug; 26(16):4015-9. PubMed ID: 27397495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel herbal formula induces cell cycle arrest and apoptosis in association with suppressing the PI3K/AKT pathway in human lung cancer A549 cells.
    Xiong F; Jiang M; Huang Z; Chen M; Chen K; Zhou J; Yin L; Tang Y; Wang M; Ye L; Zhan Z; Duan J; Fu H; Zhang X
    Integr Cancer Ther; 2014 Mar; 13(2):152-60. PubMed ID: 24105357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel harmine derivatives for tumor targeted therapy.
    Li S; Wang A; Gu F; Wang Z; Tian C; Qian Z; Tang L; Gu Y
    Oncotarget; 2015 Apr; 6(11):8988-9001. PubMed ID: 25940702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and structure-activity relationships of harmine derivatives as potential antitumor agents.
    Cao R; Fan W; Guo L; Ma Q; Zhang G; Li J; Chen X; Ren Z; Qiu L
    Eur J Med Chem; 2013 Feb; 60():135-43. PubMed ID: 23291116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tetrandrine induces apoptosis by activating reactive oxygen species and repressing Akt activity in human hepatocellular carcinoma.
    Liu C; Gong K; Mao X; Li W
    Int J Cancer; 2011 Sep; 129(6):1519-31. PubMed ID: 21128229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel derivative of aminobenzenesulfonamide (3c) induces apoptosis in colorectal cancer cells through ROS generation and inhibits cell migration.
    Al-Khayal K; Alafeefy A; Vaali-Mohammed MA; Mahmood A; Zubaidi A; Al-Obeed O; Khan Z; Abdulla M; Ahmad R
    BMC Cancer; 2017 Jan; 17(1):4. PubMed ID: 28049506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and cytotoxic activities of 1-benzylidine substituted beta-carboline derivatives.
    Cao R; Yi W; Wu Q; Guan X; Feng M; Ma C; Chen Z; Song H; Peng W
    Bioorg Med Chem Lett; 2008 Dec; 18(24):6558-61. PubMed ID: 18952426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arenobufagin, a natural bufadienolide from toad venom, induces apoptosis and autophagy in human hepatocellular carcinoma cells through inhibition of PI3K/Akt/mTOR pathway.
    Zhang DM; Liu JS; Deng LJ; Chen MF; Yiu A; Cao HH; Tian HY; Fung KP; Kurihara H; Pan JX; Ye WC
    Carcinogenesis; 2013 Jun; 34(6):1331-42. PubMed ID: 23393227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of novel antitumor nitric oxide-donating β-elemene hybrids through inhibiting the PI3K/Akt pathway.
    Chen J; Wang T; Xu S; Zhang P; Lin A; Wu L; Yao H; Xie W; Zhu Z; Xu J
    Eur J Med Chem; 2017 Jul; 135():414-423. PubMed ID: 28463784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knockdown of miR-25 increases the sensitivity of liver cancer stem cells to TRAIL-induced apoptosis via PTEN/PI3K/Akt/Bad signaling pathway.
    Feng X; Jiang J; Shi S; Xie H; Zhou L; Zheng S
    Int J Oncol; 2016 Dec; 49(6):2600-2610. PubMed ID: 27840896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 15d-PGJ2 induces apoptosis by reactive oxygen species-mediated inactivation of Akt in leukemia and colorectal cancer cells and shows in vivo antitumor activity.
    Shin SW; Seo CY; Han H; Han JY; Jeong JS; Kwak JY; Park JI
    Clin Cancer Res; 2009 Sep; 15(17):5414-25. PubMed ID: 19690198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isoorientin induces apoptosis through mitochondrial dysfunction and inhibition of PI3K/Akt signaling pathway in HepG2 cancer cells.
    Yuan L; Wang J; Xiao H; Xiao C; Wang Y; Liu X
    Toxicol Appl Pharmacol; 2012 Nov; 265(1):83-92. PubMed ID: 23026832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel compound modified from tanshinone inhibits tumor growth in vivo via activation of the intrinsic apoptotic pathway.
    Tian HL; Yu T; Xu NN; Feng C; Zhou LY; Luo HW; Chang DC; Le XF; Luo KQ
    Cancer Lett; 2010 Nov; 297(1):18-30. PubMed ID: 20494511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor activity of ZSTK474, a new phosphatidylinositol 3-kinase inhibitor.
    Yaguchi S; Fukui Y; Koshimizu I; Yoshimi H; Matsuno T; Gouda H; Hirono S; Yamazaki K; Yamori T
    J Natl Cancer Inst; 2006 Apr; 98(8):545-56. PubMed ID: 16622124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PI3K/Akt inhibitor LY294002 potentiates homoharringtonine antimyeloma activity in myeloma cells adhered to stromal cells and in SCID mouse xenograft.
    Chen P; Wen X; Wang B; Hou D; Zou H; Yuan Q; Yang H; Xie J; Huang H
    Ann Hematol; 2018 May; 97(5):865-875. PubMed ID: 29450644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.